Tarsons Products Limited (TARSONS) - Total Liabilities
Based on the latest financial reports, Tarsons Products Limited (TARSONS) has total liabilities worth Rs5.37 Billion INR (≈ $58.08 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tarsons Products Limited - Total Liabilities Trend (2019–2025)
This chart illustrates how Tarsons Products Limited's total liabilities have evolved over time, based on quarterly financial data. See Tarsons Products Limited (TARSONS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tarsons Products Limited Competitors by Total Liabilities
The table below lists competitors of Tarsons Products Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INFOM
KLSE:0265
|
Malaysia | RM244.87 Million |
|
AGV Products Corp
TW:1217
|
Taiwan | NT$7.35 Billion |
|
Cristales
SN:CRISTALES
|
Chile | CL$356.92 Billion |
|
Goodbaby International Holdings Limited
F:GBH
|
Germany | €4.34 Billion |
|
ProQR Therapeutics BV
NASDAQ:PRQR
|
USA | $67.28 Million |
|
Portman Ridge Finance Corp
NASDAQ:PTMN
|
USA | $336.54 Million |
|
Ilshin Spinnin
KO:003200
|
Korea | ₩171.07 Billion |
|
Ecomate Holdings Bhd
KLSE:0239
|
Malaysia | RM65.68 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Tarsons Products Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TARSONS market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tarsons Products Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tarsons Products Limited (2019–2025)
The table below shows the annual total liabilities of Tarsons Products Limited from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs4.50 Billion ≈ $48.65 Million |
+25.19% |
| 2024-03-31 | Rs3.59 Billion ≈ $38.86 Million |
+129.77% |
| 2023-03-31 | Rs1.56 Billion ≈ $16.91 Million |
+187.48% |
| 2022-03-31 | Rs543.96 Million ≈ $5.88 Million |
+5.39% |
| 2021-03-31 | Rs516.12 Million ≈ $5.58 Million |
+0.93% |
| 2020-03-31 | Rs511.37 Million ≈ $5.53 Million |
-33.32% |
| 2019-03-31 | Rs766.85 Million ≈ $8.29 Million |
-- |
About Tarsons Products Limited
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusable… Read more